Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects
- PMID: 28779462
- PMCID: PMC5797516
- DOI: 10.1007/s40262-017-0576-7
Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects
Abstract
Background: Differences in plasma protein levels observed between children and adults can alter the extent of xenobiotic binding in plasma, resulting in divergent patterns of exposure.
Objective: This study aims to quantify the ontogeny of α1-acid glycoprotein in both healthy and infected subjects.
Methods: Data pertaining to α1-acid glycoprotein from healthy subjects were compiled over 26 different publications. For subjects diagnosed or suspected of infection, α1-acid glycoprotein levels were obtained from 214 individuals acquired over three clinical investigations. The analysis evaluated the use of linear, power, exponential, log-linear, and sigmoid E max models to describe the ontogeny of α1-acid glycoprotein. Utility of the derived ontogeny equation for estimation of pediatric fraction unbound was evaluated using average-fold error and absolute average-fold error as measures of bias and precision, respectively. A comparison to fraction unbound estimates derived using a previously proposed linear equation was also instituted.
Results: The sigmoid E max model provided the comparatively best depiction of α1-acid glycoprotein ontogeny in both healthy and infected subjects. Despite median α1-acid glycoprotein levels in infected subjects being more than two-fold greater than those observed in healthy subjects, a similar ontogeny pattern was observed when levels were normalized toward adult levels. For estimation of pediatric fraction unbound, the α1-acid glycoprotein ontogeny equation derived from this work (average fold error 0.99; absolute average fold error 1.24) provided a superior predictive performance in comparison to the previous equation (average fold error 0.74; absolute average fold error 1.45).
Conclusion: The current investigation depicts a proficient modality for estimation of protein binding in pediatrics and will, therefore, aid in reducing uncertainty associated with pediatric pharmacokinetic predictions.
Figures
Similar articles
-
Evaluation of models for predicting pediatric fraction unbound in plasma for human health risk assessment.J Toxicol Environ Health A. 2021 Jan 17;84(2):67-83. doi: 10.1080/15287394.2020.1835761. Epub 2020 Oct 26. J Toxicol Environ Health A. 2021. PMID: 33106114
-
Plasma protein binding of tamsulosin hydrochloride in renal disease: role of alpha1-acid glycoprotein and possibility of binding interactions.Eur J Clin Pharmacol. 1999 Aug;55(6):437-43. doi: 10.1007/s002280050653. Eur J Clin Pharmacol. 1999. PMID: 10492056 Clinical Trial.
-
Impact of Interindividual Differences in Plasma Fraction Unbound on the Pharmacokinetics of a Novel Syk Kinase Inhibitor in Beagle Dogs.Drug Metab Dispos. 2021 Sep;49(9):736-742. doi: 10.1124/dmd.121.000409. Epub 2021 Jun 16. Drug Metab Dispos. 2021. PMID: 34135088
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.Drug Metab Dispos. 2016 Jul;44(7):924-33. doi: 10.1124/dmd.116.069559. Epub 2016 Apr 14. Drug Metab Dispos. 2016. PMID: 27079249 Review.
Cited by
-
CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions.Pharmaceutics. 2024 Apr 1;16(4):484. doi: 10.3390/pharmaceutics16040484. Pharmaceutics. 2024. PMID: 38675145 Free PMC article. Review.
-
Physiologically Based Pharmacokinetics Modeling in the Neonatal Population-Current Advances, Challenges, and Opportunities.Pharmaceutics. 2023 Nov 3;15(11):2579. doi: 10.3390/pharmaceutics15112579. Pharmaceutics. 2023. PMID: 38004559 Free PMC article. Review.
-
Assessing Dose-Exposure-Response Relationships of Miltefosine in Adults and Children using Physiologically-Based Pharmacokinetic Modeling Approach.Pharm Res. 2023 Dec;40(12):2983-3000. doi: 10.1007/s11095-023-03610-0. Epub 2023 Oct 10. Pharm Res. 2023. PMID: 37816929 Free PMC article.
-
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling.Pharmaceutics. 2023 Sep 19;15(9):2348. doi: 10.3390/pharmaceutics15092348. Pharmaceutics. 2023. PMID: 37765316 Free PMC article.
-
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.Eur J Pediatr. 2023 Sep;182(9):4143-4152. doi: 10.1007/s00431-023-05103-z. Epub 2023 Jul 12. Eur J Pediatr. 2023. PMID: 37436522
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical